Profile data is unavailable for this security.
About the company
GuangYuYuan Chinese Herbal Medicine Co.,Ltd. is principally engaged in pharmaceutical distribution and advertising agency services. The Company deals with over-the-counter (OTC) drugs, prescription pharmaceuticals, drug raw materials and veterinary medicines, which include products such as Dioscornin Tablets, Benproperine Phosphate Dilayer Sustained Release Tablets, Aceclofena Capsules, Norfloxaxin Capsules and Cefadroxil Dispersible Tablets, among others. Through its subsidiaries and affiliates, the Company is involved in the manufacture and distribution of pharmaceuticals. It distributes its products in domestic and overseas markets.
- Revenue in CNY (TTM)1.39bn
- Net income in CNY82.37m
- Incorporated1996
- Employees1.74k
- LocationGuangYuYuan Chinese Herbal Medicine Co Ltd6F, Tower A, Liren Technology ParkNo. 52 High-Tech RoadHigh-Tech ZoneTAIYUAN 030000ChinaCHN
- Phone+86 3 517099061
- Fax+86 3 517099130
- Websitehttps://www.guangyuyuan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanjing Vazyme Biotech Co Ltd | 1.34bn | -29.64m | 8.35bn | 2.87k | -- | 2.17 | -- | 6.21 | -0.0817 | -0.0817 | 3.98 | 9.66 | 0.2715 | 1.10 | 2.75 | 468,919.20 | -0.6649 | 9.69 | -0.8034 | 11.88 | 68.89 | 69.81 | -2.45 | 20.70 | 3.34 | -- | 0.1832 | 35.88 | 7.15 | 38.71 | 74.50 | -- | 30.38 | -- |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 3.13bn | 234.36m | 8.36bn | 6.13k | 35.71 | 1.77 | -- | 2.67 | 0.4136 | 0.4136 | 5.50 | 8.33 | 0.459 | 2.03 | 5.49 | 510,570.90 | 3.29 | 5.72 | 4.42 | 8.14 | 67.90 | 72.85 | 7.18 | 9.42 | 1.73 | 47.38 | 0.0006 | 18.39 | -19.86 | -3.11 | -15.58 | -5.02 | -0.5518 | -- |
| Harbin Pharmaceutical Group Co Ltd | 15.94bn | 449.15m | 8.89bn | 9.85k | 19.79 | 1.57 | -- | 0.5577 | 0.1783 | 0.1783 | 6.33 | 2.25 | 1.12 | 5.90 | 3.34 | -- | 3.42 | 1.58 | 8.28 | 4.28 | 25.83 | 24.86 | 3.04 | 1.51 | 1.16 | 17.44 | 0.1628 | 0.00 | 4.65 | 6.47 | 59.10 | 62.32 | 20.92 | -- |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.39bn | 82.37m | 8.89bn | 1.74k | 107.97 | 5.39 | -- | 6.40 | 0.1683 | 0.1683 | 2.84 | 3.37 | 0.5711 | 0.6215 | 4.13 | 800,359.30 | 3.51 | -2.57 | 5.10 | -3.94 | 66.36 | 68.69 | 6.15 | -6.95 | 1.16 | 17.91 | 0.0336 | -- | -4.87 | 0.071 | -17.35 | -10.56 | -36.84 | -- |
| Frontier Biotechnologies Inc | 141.20m | -167.73m | 9.03bn | 302.00 | -- | 9.20 | -- | 63.98 | -0.4478 | -0.4478 | 0.377 | 2.62 | 0.0775 | 1.78 | 2.74 | 467,559.50 | -9.21 | -12.65 | -12.08 | -14.50 | 32.51 | 18.59 | -118.79 | -333.96 | 2.58 | -- | 0.3472 | -- | 13.32 | 44.07 | 38.78 | -- | -35.01 | -- |
| KPC Pharmaceuticals Inc | 7.70bn | 530.05m | 9.45bn | 5.28k | 17.66 | 1.78 | -- | 1.23 | 0.7067 | 0.7067 | 10.21 | 7.01 | 0.6987 | 2.98 | 2.48 | 1,458,805.00 | 6.21 | 5.65 | 11.19 | 9.98 | 41.77 | 43.07 | 8.89 | 6.71 | 1.58 | -- | 0.1981 | 34.63 | -0.3408 | 0.6839 | 19.86 | 7.36 | -25.55 | 8.45 |
Data as of Feb 11 2026. Currency figures normalised to GuangYuYuan Chinese Herbal Medicine Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 4.51m | 0.92% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 3.69m | 0.75% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 3.61m | 0.74% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 3.48m | 0.71% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.41m | 0.49% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2025 | 1.34m | 0.27% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 1.27m | 0.26% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.02m | 0.21% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 977.22k | 0.20% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 436.90k | 0.09% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
